Gilead

Why experts and activists are up in arms over the grant of a patent for a blockbuster hepatitis C drug
Law / Commentary
Why experts and activists are up in arms over the grant of a patent for a blockbuster hepatitis C drug
Vidya Krishnan
What Happened to the Indian Official that Rejected the US Drug Company Gilead's Patent Application in 2015
Government / News
What Happened to the Indian Official that Rejected the US Drug Company Gilead's Patent Application in 2015
Mandakini Gahlot , Vidya Krishnan
Health / Reportage How big pharma and the Indian government are letting millions of patients down Mandakini Gahlot, Vidya Krishnan